Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment.
Blake
G
G
Department of Neurology, Beaumont Hospital, Dublin, Ireland.
Murphy
S
S
D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000628:therapy*; D009157:Myasthenia Gravis / Q000209:etiology*
D000276:Adjuvants, Immunologic; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a